miR-21 in the Extracellular Vesicles (EVs) of Cerebrospinal Fluid (CSF): A Platform for Glioblastoma Biomarker Development

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Akers, Johnny C ^a   Ramakrishnan, Valya ^a   Kim, Ryan ^a   Skog, Johan ^b   Nakano, Ichiro ^c   Pingle, Sandeep ^d   Kalinina, Juliya ^f   Hua, Wei ^g   Kesari, Santosh ^d   Mao, Ying ^g   Breakefield, Xandra O ^e   Hochberg, Fred H ^e   Van Meir, Erwin G ^f   Carter, Bob S ^a   Chen, Clark C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Exosome Diagnostics Inc   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 103; MICRORNA 21; RNA 18S; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CELL COUNT; CELL ISOLATION; CELL LEVEL; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; GAPDH GENE; GENE DOSAGE; GENE OVEREXPRESSION; GLIOBLASTOMA; HOUSEKEEPING GENE; HUMAN; HUMAN CELL; MEMBRANE VESICLE; POLYMERASE CHAIN REACTION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; REFERENCE VALUE; RNA ANALYSIS; RNA TRANSCRIPTION; SENSITIVITY AND SPECIFICITY; TUMOR CELL LINE;

CELL LINE, TUMOR; CEREBROSPINAL FLUID; GLIOBLASTOMA; HUMANS; MICRORNAS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL, 18S; TUMOR MARKERS, BIOLOGICAL;

EID: 84886938691     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078115     Document Type: Article

References (80)

1. Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, et al. (2012) Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin 60: 166-193. PubMed: 20445000.
2. Grossman SA, Batara JF, (2004) Current management of glioblastoma multiforme. Semin Oncol 31: 635-644. doi:10.1053/j.seminoncol.2004.07.005. PubMed: 15497116.
3. Sorensen AG, Batchelor TT, Wen PY, Zhang WT, Jain RK, (2008) Response criteria for glioma. Nat Clin Pract Oncol 5: 634-644. doi:10.1038/ncponc1204. PubMed: 18711427.
4. Teodori L, Albertini MC, Uguccioni F, Falcieri E, Rocchi MB, et al. (2006) Static magnetic fields affect cell size, shape, orientation, and membrane surface of human glioblastoma cells, as demonstrated by electron, optic, and atomic force microscopy. Cytometry A 69: 75-85. PubMed: 16419064.
5. Air EL, Leach JL, Warnick RE, McPherson CM, (2009) Comparing the risks of frameless stereotactic biopsy in eloquent and noneloquent regions of the brain: a retrospective review of 284 cases. J Neurosurg 111: 820-824. doi:10.3171/2009.3.JNS081695. PubMed: 19408980.
6. Chen CC, Hsu PW, Erich Wu TW, Lee ST, Chang CN, et al. (2009) Stereotactic brain biopsy: Single center retrospective analysis of complications. Clin Neurol Neurosurg 111: 835-839. doi:10.1016/j.clineuro.2009.08.013. PubMed: 19765887.
7. Skog J, Würdinger T, van Rijn S, Meijer DH, Gainche L, et al. (2008) Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 10: 1470-1476. doi:10.1038/ncb1800. PubMed: 19011622.
8. Balaj L, Lessard R, Dai L, Cho YJ, Pomeroy SL, et al. (2011) Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences. Nat Commun 2: 180. doi:10.1038/ncomms1180. PubMed: 21285958.
9. Noerholm M, Balaj L, Limperg T, Salehi A, Zhu LD, et al. (2012) RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls. BMC Cancer 12: 22. doi:10.1186/1471-2407-12-22. PubMed: 22251860.
10. Hong BS, Cho JH, Kim H, Choi EJ, Rho S, et al. (2009) Colorectal cancer cell-derived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells. BMC Genomics 10: 556. doi:10.1186/1471-2164-10-556. PubMed: 19930720.
11. Rabinowits G, Gerçel-Taylor C, Day JM, Taylor DD, Kloecker GH, (2009) Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer 10: 42-46. doi:10.3816/CLC.2009.n.006. PubMed: 19289371.
12. Camussi G, Deregibus MC, Bruno S, Grange C, Fonsato V, et al. (2011) Exosome/microvesicle-mediated epigenetic reprogramming of cells. Am J Cancer Res 1: 98-110. PubMed: 21969178.
13. Street JM, Barran PE, Mackay CL, Weidt S, Balmforth C, et al. (2012) Identification and proteomic profiling of exosomes in human cerebrospinal fluid. J Transl Med 10: 5. doi:10.1186/1479-5876-10-S3-O5. PubMed: 22221959.
14. Shao H, Chung J, Balaj L, Charest A, Bigner DD, et al. (2012) Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy. Nat Med 18: 1835-1840. doi:10.1038/nm.2994. PubMed: 23142818.
15. Taylor DD, Gercel-Taylor C, (2008) MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 110: 13-21. doi:10.1016/j.ygyno.2008.04.033. PubMed: 18589210.
16. Thery C, (2011) Exosomes: secreted vesicles and intercellular communications. F1000. Biol Reprod 3: 15.
17. Li L, Zhu D, Huang L, Zhang J, Bian Z, et al. (2012) Argonaute 2 complexes selectively protect the circulating microRNAs in cell-secreted microvesicles. PLOS ONE 7: e46957. doi:10.1371/journal.pone.0046957. PubMed: 23077538.
18. Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, et al. (1996) B lymphocytes secrete antigen-presenting vesicles. J Exp Med 183: 1161-1172. doi:10.1084/jem.183.3.1161. PubMed: 8642258.
19. Blanchard N, Lankar D, Faure F, Regnault A, Dumont C, et al. (2002) TCR activation of human T cells induces the production of exosomes bearing the TCR/CD3/zeta complex. J Immunol 168: 3235-3241. PubMed: 11907077.
20. Taylor DD, Akyol S, Gercel-Taylor C, (2006) Pregnancy-Associated Exosomes and Their Modulation of T Cell Signaling. J Immunol 176: 1534-1542. PubMed: 16424182.
21. Alberts B, Johnson A, Lewis J, (2002) Molecular Biology of the Cell. New York: Garland Sciences.
22. D'Souza-Schorey C, Clancy JW, (2012) Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers. Genes Dev 26: 1287-1299. doi:10.1101/gad.192351.112. PubMed: 22713869.
23. Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, et al. (2008) Detection of microRNA expression in human peripheral blood microvesicles. PLOS ONE 3: e3694. doi:10.1371/journal.pone.0003694. PubMed: 19002258.
24. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. doi:10.1006/meth.2001.1262. PubMed: 11846609.
25. VanGuilder HD, Vrana KE, Freeman WM, (2008) Twenty-five years of quantitative PCR for gene expression analysis. BioTechniques 44: 619-626. PubMed: 18474036.
26. Bustin SA, (2000) Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 25: 169-193. doi:10.1677/jme.0.0250169. PubMed: 11013345.
27. Suzuki T, Higgins PJ, Crawford DR, (2000) Control selection for RNA quantitation. BioTechniques 29: 332-337. PubMed: 10948434.
28. Thellin O, Zorzi W, Lakaye B, De Borman B, Coumans B, et al. (1999) Housekeeping genes as internal standards: use and limits. J Biotechnol 75: 291-295. doi:10.1016/S0168-1656(99)00163-7. PubMed: 10617337.
29. Chan JA, Krichevsky AM, Kosik KS, (2005) MicroRNA-21 Is an Antiapoptotic Factor in Human Glioblastoma Cells. Cancer Res 65: 6029-6033. doi:10.1158/0008-5472.CAN-05-0137. PubMed: 16024602.
30. Witwer KW, Buzás EI, Bemis LT, Lässer C, Lötvall J, et al,. (In press) Standardisation of sample collection, isolation and analysis methods in extracellular vesicle research: A position paper arising from the 2012 ISEV Workshop on RNA in extracellular vesicles. Journal of Extracellular Vesicles.
31. Ishii N, Maier D, Merlo A, Tada M, Sawamura Y, et al. (1999) Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines. Brain Pathol 9: 469-479. doi:10.1111/j.1750-3639.1999.tb00536.x. PubMed: 10416987.
32. Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, et al. (1973) In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 51: 1417-1423. PubMed: 4357758.
33. Pontén J, Saksela E, (1967) Two established in vitro cell lines from human mesenchymal tumours. Int J Cancer 2: 434-447. doi:10.1002/ijc.2910020505. PubMed: 6081590.
34. DuBridge RB, Tang P, Hsia HC, Leong PM, Miller JH, et al. (1987) Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol 7: 379-387. PubMed: 3031469.
35. Joshi K, Banasavadi-Siddegowda Y, Mo X, Kim SH, Mao P, et al. (2013) MELK-dependent FOXM1 Phosphorylation is Essential for Proliferation of Glioma Stem Cells. Stem Cells, 31: 1051-63. PubMed: 23404835.
36. Ng K, Nitta M, Hu L, Kesari S, Kung A, et al. (2009) A small interference RNA screen revealed proteasome inhibition as strategy for glioblastoma therapy. Clin Neurosurg 56: 107-118. PubMed: 20214041.
37. Gu C, Banasavadi-Siddegowda YK, Joshi K, Nakamura Y, Kurt H, et al. (2013) Tumor-specific Activation of the c-JUN/MELK Pathway Regulates Glioma Stem Cell Growth in a p53-dependent Manner. Stem Cells.
38. Théry C, Amigorena S, Raposo G, Clayton A, (2006) Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol Chapter 3Unit 3.22: Unit 3 22. PubMed: 18228490.
39. Clark MJ, Homer N, O'Connor BD, Chen Z, Eskin A, et al. (2010) U87MG Decoded: The Genomic Sequence of a Cytogenetically Aberrant Human Cancer Cell Line. PLOS Genet 6: e1000832. PubMed: 20126413.
40. Trang P, Wiggins JF, Daige CL, Cho C, Omotola M, et al. (2011) Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice. Mol Ther 19: 1116-1122. doi:10.1038/mt.2011.48. PubMed: 21427705.
41. Stigler S, (1989) Francis Galton's Account of the Invention of Correlation. Stat Sci 4: 7.
42. STUDENT (1908) THE PROBABLE ERROR OF A MEAN. Biometrika 6: 1-25. doi:10.2307/2331554.
43. Zweig MH, Campbell G, (1993) Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 39: 561-577. PubMed: 8472349.
44. Wotschofsky Z, Meyer H-A, Jung M, Fendler A, Wagner I, et al. (2011) Reference genes for the relative quantification of microRNAs in renal cell carcinomas and their metastases. Anal Biochem 417: 233-241. doi:10.1016/j.ab.2011.06.009. PubMed: 21741950.
45. Gonda DD, Akers JC, Kim R, Kalkanis SN, Hochberg FH, et al. (2013) Neuro-oncologic Applications of Exosomes, Microvesicles, and Other Nano-Sized Extracellular Particles. Neurosurgery 72: 501-510. doi:10.1227/NEU.0b013e3182846e63. PubMed: 23277376.
46. Huan J, Hornick NI, Shurtleff MJ, Skinner AM, Goloviznina NA, et al. (2013) RNA Trafficking by Acute Myelogenous Leukemia Exosomes. Cancer Res 73: 918-929. doi:10.1158/0008-5472.CAN-12-2184. PubMed: 23149911.
47. Rana S, Malinowska K, Zöller M, (2013) Exosomal Tumor MicroRNA Modulates Premetastatic Organ Cells. Neoplasia 15: 281-295. PubMed: 23479506.
48. Xiao D, Ohlendorf J, Chen Y, Taylor DD, Rai SN, et al. (2012) Identifying mRNA, MicroRNA and Protein Profiles of Melanoma Exosomes. PLOS ONE 7: e46874. doi:10.1371/journal.pone.0046874. PubMed: 23056502.
49. de Biase D, Visani M, Morandi L, Marucci G, Taccioli C, et al. (2012) miRNAs Expression Analysis in Paired Fresh/Frozen and Dissected Formalin Fixed and Paraffin Embedded Glioblastoma Using Real-Time PCR. PLOS ONE 7: e35596. doi:10.1371/journal.pone.0035596. PubMed: 22530056.
50. Bangert A, Cristofanon S, Eckhardt I, Abhari BA, Kolodziej S, et al. (2012) Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc-mediated downregulation of cFLIP. Oncogene 31: 4677-4688. doi:10.1038/onc.2011.614. PubMed: 22266862.
51. Wang H, Shen W, Huang H, Hu L, Ramdas L, et al. (2003) Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes. Cancer Res 63: 4315-4321. PubMed: 12907597.
52. Jarboe JS, Johnson KR, Choi Y, Lonser RR, Park JK, (2007) Expression of interleukin-13 receptor alpha2 in glioblastoma multiforme: implications for targeted therapies. Cancer Res 67: 7983-7986. doi:10.1158/0008-5472.CAN-07-1493. PubMed: 17804706.
53. Ehtesham M, Winston JA, Kabos P, Thompson RC, (2006) CXCR4 expression mediates glioma cell invasiveness. Oncogene 25: 2801-2806. doi:10.1038/sj.onc.1209302. PubMed: 16407848.
54. Santangelo PJ, Alonas E, Jung J, Lifland AW, Zurla C, (2012) Probes for intracellular RNA imaging in live cells. Methods Enzymol 505: 383-399. doi:10.1016/B978-0-12-388448-0.00028-0. PubMed: 22289464.
55. Barber RD, Harmer DW, Coleman RA, Clark BJ, (2005) GAPDH as a housekeeping gene: analysis of GAPDH mRNA expression in a panel of 72 human tissues. Physiol Genomics 21: 389-395. doi:10.1152/physiolgenomics.00025.2005. PubMed: 15769908.
56. Wada Y, Li D, Merley A, Zukauskas A, Aird WC, et al. (2011) A multi-gene transcriptional profiling approach to the discovery of cell signature markers. Cytotechnology 63: 25-33. doi:10.1007/s10616-010-9315-8. PubMed: 20972619.
57. Visani M, de Biase D, Marucci G, Taccioli C, Baruzzi A, et al. (2013) Definition of miRNAs expression profile in glioblastoma samples: the relevance of non-neoplastic brain reference. PLOS ONE 8: e55314. doi:10.1371/journal.pone.0055314. PubMed: 23383149.
58. Filipe V, Hawe A, Jiskoot W, (2010) Critical evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates. Pharm Res 27: 796-810. doi:10.1007/s11095-010-0073-2. PubMed: 20204471.
59. Wright M, (2012) Nanoparticle tracking analysis for the multiparameter characterization and counting of nanoparticle suspensions. Methods Mol Biol 906: 511-524. PubMed: 22791460.
60. Gercel-Taylor C, Atay S, Tullis RH, Kesimer M, Taylor DD, (2012) Nanoparticle analysis of circulating cell-derived vesicles in ovarian cancer patients. Anal Biochem 428: 44-53. doi:10.1016/j.ab.2012.06.004. PubMed: 22691960.
61. Vallhov H, Gutzeit C, Johansson SM, Nagy N, Paul M, et al. (2011) Exosomes containing glycoprotein 350 released by EBV-transformed B cells selectively target B cells through CD21 and block EBV infection in vitro. J Immunol 186: 73-82. doi:10.4049/jimmunol.1001145. PubMed: 21106852.
62. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, et al. (2004) Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64: 7011-7021. doi:10.1158/0008-5472.CAN-04-1364. PubMed: 15466194.
63. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, et al. (2006) Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9: 391-403. doi:10.1016/j.ccr.2006.03.030. PubMed: 16697959.
64. Caby MP, Lankar D, Vincendeau-Scherrer C, Raposo G, Bonnerot C, (2005) Exosomal-like vesicles are present in human blood plasma. Int Immunol 17: 879-887. doi:10.1093/intimm/dxh267. PubMed: 15908444.
65. Chang A, (2013) StatsToDo website. Available: www.statstodo.com. Accessed 2013 March 4.
66. Raposo Ga, Stoorvogel W (2013) Extracellular vesicles: Exosomes, microvesicles, and friends. J Cell Biol 200: 373-383. doi:10.1083/jcb.201211138. PubMed: 23420871.
67. Akers JC, Gonda D, Kim R, Carter BS, Chen CC, (2013) Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies. J Neuro Oncol 113: 1-11. doi:10.1007/s11060-013-1084-8. PubMed: 23456661.
68. Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, et al. (2011) Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A 108: 5003-5008. doi:10.1073/pnas.1019055108. PubMed: 21383194.
69. Boon RA, Vickers KC, (2013) Intercellular transport of microRNAs. Arterioscler Thromb Vasc Biol 33: 186-192. doi:10.1161/ATVBAHA.112.300139. PubMed: 23325475.
70. Teplyuk NM, Mollenhauer B, Gabriely G, Giese A, Kim E, et al. (2012) MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity. Neuro-Oncology 14: 689-700. doi:10.1093/neuonc/nos074. PubMed: 22492962.
71. Guduric-Fuchs J, O'Connor A, Cullen A, Harwood L, Medina RJ, et al. (2012) Deep sequencing reveals predominant expression of miR-21 amongst the small non-coding RNAs in retinal microvascular endothelial cells. J Cell Biochem 113: 2098-2111. doi:10.1002/jcb.24084. PubMed: 22298343.
72. Qi L, Bart J, Tan LP, Platteel I, Sluis Tv, et al. (2009) Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma. BMC Cancer 9: 163. doi:10.1186/1471-2407-9-163. PubMed: 19473551.
73. Deftereos G, Corrie SR, Feng Q, Morihara J, Stern J, et al. (2011) Expression of Mir-21 and Mir-143 in Cervical Specimens Ranging from Histologically Normal through to Invasive Cervical Cancer. PLOS ONE 6: e28423. doi:10.1371/journal.pone.0028423. PubMed: 22194833.
74. Bhagat TD, Zhou L, Sokol L, Kessel R, Caceres G, et al. (2013) miR-21 mediates hematopoietic suppression in MDS by activating TGF-beta signaling. Blood 121: 2875-2881. doi:10.1182/blood-2011-12-397067. PubMed: 23390194.
75. Wang Q, Li P, Li A, Jiang W, Wang H, et al. (2012) Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma. J Exp Clin Cancer Res 31: 97. doi:10.1186/1756-9966-31-97. PubMed: 23174013.
76. Huggett J, Dheda K, Bustin S, Zumla A, (2005) Real-time RT-PCR normalisation; strategies and considerations. Genes Immun 6: 279-284. doi:10.1038/sj.gene.6364190. PubMed: 15815687.
77. Tran Thang NN, Derouazi M, Philippin G, Arcidiaco S, Di Berardino-Besson W, et al. (2010) Immune infiltration of spontaneous mouse astrocytomas is dominated by immunosuppressive cells from early stages of tumor development. Cancer Res 70: 4829-4839. doi:10.1158/0008-5472.CAN-09-3074. PubMed: 20501837.
78. Ghosh A, Chaudhuri S, (2010) Microglial action in glioma: a boon turns bane. Immunol Lett 131: 3-9. doi:10.1016/j.imlet.2010.03.003. PubMed: 20338195.
79. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, et al. (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17: 98-110. doi:10.1016/j.ccr.2009.12.020. PubMed: 20129251.
80. Møller HG, Rasmussen AP, Andersen HH, Johnsen KB, Henriksen M, et al. (2013) A systematic review of microRNA in glioblastoma multiforme: micro-modulators in the mesenchymal mode of migration and invasion. Mol Neurobiol 47: 131-144. doi:10.1007/s12035-012-8349-7. PubMed: 23054677.